US Recession Pharma Analytics

White Paper

How Will The Next Great Recession Affect The US Pharma Industry?

The US will have another recession as certain as night follows day. The business cycle has not been outlawed nor made extinct, contrary to the overly optimistic views of macroecono ...

Merger and Acquisitions

White Paper

Do Pharma Mergers And Acquisitions Improve R&D Productivity And Increase Shareholder Value?

Mergers & acquisitions (M&As) have long been used as a critical strategic instrument by pharmaceutical company executives to spur R&D innovation, sustain financial grow ...

Growing Attention Being Paid To Pharma Company Rebates And Discounts

White Paper

Growing Attention Being Paid To Pharma Company Rebates And Discounts

Pharma companies need to better understand how to manage rebates and discounts, while also developing a broader view of the effect on patients and the healthcare system. ...

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US

White Paper

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US

This white paper explores the unique challenges of ODs for RDs and the different approaches needed to address specific questions for their successful commercialization that vary fr ...

Perspectives On Pharma Company Use Of Open Payments Data

White Paper

Perspectives On Pharma Company Use Of Open Payments Data

This paper provides a detailed analysis on the role and effects of “Sunshine Laws” and payments made to providers as seen from published empirical evidence, intricacies and cha ...

How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

White Paper

How Will The 2018 Midterm Congressional Election Results Affect The US Pharma Industry?

The 2018 Congressional midterm elections are over after a bitter political fight. The voters have spoken. We are back to divided government, with Democrats controlling the House, a ...

Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

White Paper

Is The CVS-Aetna Merger A Pharma Industry Transformative Event?

US antitrust officials recently approved the proposed $69 billion CVS-Aetna merger. This merger follows a similar action taken by the Justice Department to approve the Cigna-Expres ...

The Causes and Solutions of Chronic Drug Shortages in the United States

White Paper

The Causes and Solutions of Chronic Drug Shortages in the United States

While recent empirical research has exposed an array of causes for drug shortages, the application of better analytics has now also been cited as needed to account for these effect ...

The Reasons for and Solutions to Chronic Drug Shortages in the United States

White Paper

The Reasons for and Solutions to Chronic Drug Shortages in the United States

This white paper will briefly address the questions and present the key reasons for and solutions to the existence of chronic drug shortages in the US. It will also discuss the rol ...